Cargando…

Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment

SIMPLE SUMMARY: Metastatic castration-resistant prostate cancer is still untreatable, and patients have a very short life expectancy after diagnosis. One factor that makes metastatic castration-resistant prostate cancer so aggressive and difficult to treat is neuroendocrine differentiation of prosta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiesehöfer, Marc, Czyrnik, Elena Dilara, Spahn, Martin, Ting, Saskia, Reis, Henning, Dankert, Jaroslaw Thomas, Wennemuth, Gunther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867287/ https://www.ncbi.nlm.nih.gov/pubmed/33540707 http://dx.doi.org/10.3390/cancers13030578

Ejemplares similares

The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells
por: Dankert, Jaroslaw Thomas, et al.
Publicado: (2018)

Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma
por: Dankert, Jaroslaw Thomas, et al.
Publicado: (2020)

Epiregulin expression and secretion is increased in castration-resistant prostate cancer
por: Wiesehöfer, Marc, et al.
Publicado: (2023)

Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells
por: Czyrnik, Elena D., et al.
Publicado: (2023)

CEACAM expression in an in-vitro prostatitis model
por: Kube-Golovin, Irina, et al.
Publicado: (2023)

Neuroendocrine Cells of the Prostate Derive from the Neural Crest
por: Szczyrba, Jaroslaw, et al.
Publicado: (2017)

cAMP and the Fibrous Sheath Protein CABYR (Ca(2+)-Binding Tyrosine-Phosphorylation-Regulated Protein) Is Required for 4D Sperm Movement
por: Frintrop, Linda, et al.
Publicado: (2022)

Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes
por: Szczyrba, Jaroslaw, et al.
Publicado: (2017)

C11orf94/Frey is a key regulator for male fertility by controlling Izumo1 complex assembly
por: Contreras, Whendy, et al.
Publicado: (2022)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014)

Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
por: Su, Ruopeng, et al.
Publicado: (2022)

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2022)

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
por: Brennen, W. Nathaniel, et al.
Publicado: (2021)

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2023)

Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: A Literature Review
por: Dhavale, Meera, et al.
Publicado: (2021)

Clinical relevance of androgen receptor alterations in prostate cancer
por: Jernberg, Emma, et al.
Publicado: (2017)

The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

“Splice” a way towards neuroendocrine prostate cancer
por: Zhang, Dingxiao, et al.
Publicado: (2018)

Correction to: The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
por: Zhang, Yan, et al.
Publicado: (2018)

Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
por: Nouri, Mannan, et al.
Publicado: (2014)

Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST
por: Li, Wenliang, et al.
Publicado: (2023)

Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
por: Roediger, Julia, et al.
Publicado: (2014)

Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm
por: Zhou, Jianfu, et al.
Publicado: (2020)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells
por: Azeem, Waqas, et al.
Publicado: (2017)

hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen
por: Fraser, Jennifer A., et al.
Publicado: (2019)

ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer
por: Holzmann, Christian, et al.
Publicado: (2013)

Genomic alterations in neuroendocrine prostate cancer: A systematic review and meta‐analysis
por: Chen, Junru, et al.
Publicado: (2023)

Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1(+) prostate luminal cells
por: Kwon, Oh-Joon, et al.
Publicado: (2020)

ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer
por: Choi, WonSeok William, et al.
Publicado: (2022)

Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemo-resistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals
por: Cui, Yun, et al.
Publicado: (2016)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Androgens, aging, and prostate health
por: Welén, Karin, et al.
Publicado: (2022)

Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer
por: Martens‐Uzunova, Elena S., et al.
Publicado: (2021)

Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer
por: Watanabe, Ryuta, et al.
Publicado: (2023)

Roles for androgens in mediating the sex differences of neuroendocrine and behavioral stress responses
por: Zuloaga, Damian G., et al.
Publicado: (2020)

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
por: Oh, Su Jung, et al.
Publicado: (2012)

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
por: Edlind, Merritt P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gibregc3mnirehpefm555e39ee